Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Galapagos (GLPG)
NASDAQ:GLPG
Galapagos (GLPG) Stock Price & Analysis
519 Followers
GLPG Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$28.30 - $45.21
Previous Close$29.45
Volume125.69K
Average Volume (3M)126.46K
Market Cap
$1.92B
Enterprise Value-$1.97B
Total Cash (Recent Filing)€3.68B
Total Debt (Recent Filing)€41.64M
Price to Earnings (P/E)-12.7
Beta0.47
Next Earnings
Aug 01, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.32
Shares Outstanding65,897,071
10 Day Avg. Volume115,426
30 Day Avg. Volume126,460
Standard Deviation0.11
R-Squared0.02
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)0.75
Price to Sales (P/S)8.00
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$35.67Price Target Upside22.62% Upside
Rating ConsensusHold
Number of Analyst Covering4
Galapagos News
PremiumCompany Announcements
Galapagos NV Reports Strong Q1 2024 Financials
PremiumCompany Announcements
Galapagos NV Shareholders Approve Key Resolutions
PremiumCompany Announcements
Galapagos NV Shareholders Approve Key ResolutionsPremiumCompany Announcements
Galapagos NV Unveils CAR-T Therapy Advances
Bulls Say, Bears Say
Bulls Say
Business StrategyCompletion of the transfer of Jyseleca to Alfasigma, expected to bring in steady royalty income.
EarningsJyseleca sales surpassed consensus estimates, reporting revenues higher than expected.
Product DevelopmentGalapagos is progressing with multiple promising oncology CAR T programs, showing early efficacy and safety.
Bears Say
Analyst RatingsDowngrade to Underperform as few catalysts are emerging.
CompetitionProgress of competitors negates cell therapy value proposition.
Valuation ConcernsEnterprise value shows no sign of breaking out.
---
Ownership Overview
0.00%
Insiders
5.92% Mutual Funds
1.02% Other Institutional Investors
93.06% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
GLPG FAQ
What was Galapagos’s price range in the past 12 months?
Galapagos lowest stock price was $28.30 and its highest was $45.21 in the past 12 months.
What is Galapagos’s market cap?
Currently, no data Available
When is Galapagos’s upcoming earnings report date?
Galapagos’s upcoming earnings report date is Aug 01, 2024 which is in 89 days.
How were Galapagos’s earnings last quarter?
Galapagos released its earnings results on May 02, 2024. The company reported $0.388 earnings per share for the quarter, beating the consensus estimate of -$0.084 by $0.472.
Is Galapagos overvalued?
According to Wall Street analysts Galapagos’s price is currently Undervalued.
Does Galapagos pay dividends?
Galapagos does not currently pay dividends.
What is Galapagos’s EPS estimate?
Galapagos’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Galapagos have?
Galapagos has 65,897,070 shares outstanding.
What happened to Galapagos’s price movement after its last earnings report?
Galapagos reported an EPS of $0.388 in its last earnings report, beating expectations of -$0.084. Following the earnings report the stock price went down -1.222%.
Which hedge fund is a major shareholder of Galapagos?
Among the largest hedge funds holding Galapagos’s share is PRIMECAP Management Co. It holds Galapagos’s shares valued at 28M.
---
Galapagos Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$35.67 (22.62% Upside)
$35.67 (22.62% Upside)
Blogger Sentiment
Bullish
GLPG Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 612.5K Shares
Last Quarter.
Last Quarter.
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-27.72%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-6.40%
Trailing 12-Months
Company Description
Galapagos
Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. It operates through the Research and Development and Fee-for-Services segment. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.
---
GLPG Company Deck
---
GLPG Earnings Call
Q1 2024
0:00 / 0:00
---
GLPG Stock 12 Months Forecast
Average Price Target
$35.67
▲(22.62% Upside)
Technical Analysis
Best Analysts Covering GLPG
1 Year
1 Year Success Rate
7/15 ratings generated profit
1 Year Average Return
+17.04%
reiterated a buy rating 2 months ago
Copying Phil Nadeau's trades and holding each position for 1 Year would result in 46.67% of your transactions generating a profit, with an average return of +17.04% per trade.
---